11/4
02:09 am
ogen
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
10/27
02:07 am
ogen
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
10/19
02:07 am
ogen
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
10/18
08:30 am
ogen
Oragenics, Inc. to Present at The Centurion One Capital 2nd Annual Bahamas Summit
Medium
Report
Oragenics, Inc. to Present at The Centurion One Capital 2nd Annual Bahamas Summit
10/11
02:07 am
ogen
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
10/9
07:30 am
ogen
Oragenics, Inc. Updates Shareholders on Concussion Drug Progress and Phase II Trial Preparation
Low
Report
Oragenics, Inc. Updates Shareholders on Concussion Drug Progress and Phase II Trial Preparation
10/8
08:47 am
ogen
EXCLUSIVE: Oragenics Completes Key FDA-Recognized Study For Concussion Drug Candidate [Yahoo! Finance]
High
Report
EXCLUSIVE: Oragenics Completes Key FDA-Recognized Study For Concussion Drug Candidate [Yahoo! Finance]
10/8
08:45 am
ogen
Oragenics Inc. Successfully Completes Key FDA-Recognized Study for ONP-002
High
Report
Oragenics Inc. Successfully Completes Key FDA-Recognized Study for ONP-002
10/3
02:05 am
ogen
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
9/25
02:04 am
ogen
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
9/7
02:07 am
ogen
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
9/5
04:30 pm
ogen
Oragenics, Inc. Announces Closing of Public Offering
Low
Report
Oragenics, Inc. Announces Closing of Public Offering
9/4
08:47 am
ogen
Oragenics, Inc. Announces Pricing of Public Offering [Yahoo! Finance]
Medium
Report
Oragenics, Inc. Announces Pricing of Public Offering [Yahoo! Finance]
9/4
08:42 am
ogen
Analysis-Recession fears trounce rate cut cheer in latest market selloff [Yahoo! Finance Canada]
Low
Report
Analysis-Recession fears trounce rate cut cheer in latest market selloff [Yahoo! Finance Canada]
9/4
08:36 am
ogen
Oragenics, Inc. Announces Pricing of Public Offering
Medium
Report
Oragenics, Inc. Announces Pricing of Public Offering
8/30
02:03 am
ogen
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
High
Report
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
8/22
02:13 am
ogen
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
8/21
08:45 am
ogen
Oragenics Inc. Completes Spray Dry Drug Manufacturing and Intranasal Device Filling in Anticipation of Phase IIa Clinical Trial in Concussed Patients
High
Report
Oragenics Inc. Completes Spray Dry Drug Manufacturing and Intranasal Device Filling in Anticipation of Phase IIa Clinical Trial in Concussed Patients
8/21
08:37 am
ogen
EXCLUSIVE: Oragenics Completes Spray Dry Drug Manufacturing, Intranasal Device Filling For Anticipated Mid-Stage Study For Patients With Brain Injury [Yahoo! Finance]
High
Report
EXCLUSIVE: Oragenics Completes Spray Dry Drug Manufacturing, Intranasal Device Filling For Anticipated Mid-Stage Study For Patients With Brain Injury [Yahoo! Finance]
8/16
04:30 pm
ogen
Oragenics, Inc. Provides Update on its Drug Intended to Treat Concussion and Non-Compliance with NYSE American Continued Listing Standards
High
Report
Oragenics, Inc. Provides Update on its Drug Intended to Treat Concussion and Non-Compliance with NYSE American Continued Listing Standards
8/14
08:30 am
ogen
Oragenics Inc. Shows Concussion Drug, ONP-002, Designed for Acute Field-Delivery Stable Across a Wide Temperature Range
High
Report
Oragenics Inc. Shows Concussion Drug, ONP-002, Designed for Acute Field-Delivery Stable Across a Wide Temperature Range
8/12
08:39 am
ogen
Oragenics, Inc. Announces Concussion Drug Successfully Completes FDA-Required Genotoxicity Study [Yahoo! Finance]
High
Report
Oragenics, Inc. Announces Concussion Drug Successfully Completes FDA-Required Genotoxicity Study [Yahoo! Finance]
8/12
08:30 am
ogen
Oragenics, Inc. Announces Concussion Drug Successfully Completes FDA-Required Genotoxicity Study
High
Report
Oragenics, Inc. Announces Concussion Drug Successfully Completes FDA-Required Genotoxicity Study
8/9
09:00 am
ogen
As Traumatic Brain Injuries Increase, Global Concussion Market Size Expected to Reach $10 Billion By 2032
High
Report
As Traumatic Brain Injuries Increase, Global Concussion Market Size Expected to Reach $10 Billion By 2032
8/8
10:06 am
ogen
FDA Approves Expanded Use Of Novartis' Rare Disease Drug Fabhalta For Kidney Disease [Yahoo! Finance]
High
Report
FDA Approves Expanded Use Of Novartis' Rare Disease Drug Fabhalta For Kidney Disease [Yahoo! Finance]